AlenCiken

In-Line Q4 EPS Analyst Sees Better 2nd-Half

看多
NYSE:CSLT   None
Castlight Health (NYSE: CSLT) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $40.47 million.

GUIDANCE:

Castlight Health sees FY2019 EPS of $0.00-$0.03, versus the consensus of $0.01. Castlight Health sees FY2019 revenue of $153-158 million, versus the consensus of $159.77 million.

www.barchart.com/sto...s-whats-in-the-cards

www.fool.com/investi...ed-24-on-friday.aspx


免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。